CD44 and cancer: miR-141 targeted CD44, members of Rho GTPase signaling pathway (RAC1, CDC42, CDC42EP3 and ARPC5) and EZH2 mRNAs implying possible mechanisms of its influence on invasion, cell motility, and on cancer stem cells properties [122].